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Currently, infectious bursal disease (IBD) is a highly contagious disease leading to 
huge economic losses in poultry industry. Our objective was to investigate potential 
therapeutic effects of the combined extracts of Rhizoma Dryopteridis 
crassirhizomatis and Fructus mume (RDCFM) against IBDV infection. Seventy-
two 4-week-old SPF chickens were randomly divided into six groups and inoculated 
intranasally with 0.2 ml of 10
2.5 EID50 of IBDV strain CJ801. Twenty-four hours 
post infection, the birds were orally administered with 400, 200 and 100 mg/kg BW 
of RDCFM, respectively, 125 mg/kg Astragalus polysaccharide (ASP) and saline 
water, respectively for 5 days and then monitored daily for 10 days. Finally, the 
remaining birds were euthanized to collect the sera for detecting antibodies and 
immune organs for determining the immune organs index as well as virus loads. 
The herbal extracts improved survival rate and relative body gain rate. Virus loads 
in bursa of Fabricius in herbal treated groups decreased significantly while higher 
antibody levels were detected in the three RDCFM groups as compared to those of 
ASP and infection group. These results implied that chickens administered with 
100-200 mg/kg of RDCFM for 5 days could improve protection against IBDV 
infection and RDCFM may be a promising alternative to ASP and egg yolk 
antibody. 
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To Cite This Article: Ou C, N Shi, Q Pan, D Tian, W Zeng and C He, 2013. Therapeutic efficacy of the combined 
extract of herbal medicine against infectious bursal disease in chickens. Pak Vet J, 33(3): 304-308. 
 
INTRODUCTION 
 
Rhizoma  Dryopteridis crassirhizomatis (RDC) and 
Fructus mume (FM) have been used in some herbal 
prescriptions since ancient times in China. In particular, 
RDC has been widely applied to formulate antiviral 
granules for severe patients during the severe acute 
respiratory syndrome (SARS) outbreak in 2003 (Zhao et 
al., 2007). Furthermore, RDC has been shown to possess 
anti-cancer properties (Chang et al., 2010) and anti-viral 
applications (Lee et al., 2008; Min et al., 2001). On the 
other hand, FM juice has also been shown to inhibit 
human influenza-A virus infection by inhibiting viral 
hemagglutinin attachment to host cell surfaces 
(Yingsakmongkon  et al., 2008; Zhao et al., 2007). In 
recent reports, the combination of FM, Schizandrae 
Fructus or Coptidis Rhizoma has shown an effective 
antimicrobial activity against enterohemorrhagic 
Escherichia coli infection (Lee and Stein, 2011). The 
active substances (4-hydroxycinnamic acid and 
protocatechuic acid) isolated from FM were confirmed to 
induce a better protection and improve the immune 
response for chickens inoculated with infectious bursal 
disease virus (IBDV) (Ou et al., 2011; Ou et al., 2012; 
Okwor et al., 2012). However, the combined extracts of 
RDC and FM haven’t been formulated to apply in poultry 
industry and its potential therapeutic efficacy on SPF 
chickens infected with IBDV should be evaluated.  
Infectious bursal disease is an acute, highly 
contagious disease for young chickens and is prevalent in 
chicken farms throughout the world (Eterradossi and Saif, 
2008; Lone et al., 2012 ). Moreover, IBD leads to severe 
economic losses due to high morbidity and mortality in an 
acute form or severe immunosuppression or secondary 
infections (Muller et al., 2003). However, immunity 
failure occurs at any time, thereby leading to tremendous 
difficulties in controlling IBD due to the presence of 
variant strains (Craft et al., 1990). IBDV vaccine and drug 
development must be accelerated due to the increasing 
prevalence of IBDV. Therefore, the cheap RDC was used 
RESEARCH ARTICLE Pak Vet J, 2013, 33(3): 304-308. 
 
305
for formulating a prescription with FM in this study and 
our objective was to evaluate whether RDCFM could 
provide a better protection against IBDV infection by 
increasing the immune response in chickens. 
 
MATERIALS AND METHODS 
 
Herbal medicines: Astragalus polysaccharide (ASP) 
(batch no. 20110309) was purchased from the Institute of 
Veterinary Drug and Control, China and the concentration 
of ASP was determined to be 55.0% using HPLC method 
(Chen et al., 2003). RDC and FM were purchased from a 
pharmacy (Xiyuan Traditional Medicine Hospital, 
Beijing, China) and authenticated by Professor Jianyong 
Si, Institute of Medicinal Plant Development, Chinese 
Academy of Medical Sciences and Peking Union Medical 
College. 
 
Preparation of herb extracts: A heat reflux method was 
employed for herb extraction. Briefly, RDC was ground to 
a powder using a mill and was then mixed with FM at a 
ratio of 6:4 (w/w). The mixture was soaked with an 
ethanol/water (75:25, v/v) solution (1:10, w/v) for 24 
hours. Finally, the mixture was boiled for 2 hours and 
filtered to collect the liquid extracts. Subsequently, the 
solvent was removed under vacuum using a rotary 
evaporator. The yield of the dried syrup accounted for 
23±1% of the dried herbs and the preparation was kept at 
4
oC until use. 
 
Quality control of herb extracts: Citric acid was used to 
control the FM quality according to the protocol of 
Chinese Pharmacopoeia while Dryocrassine ABBA was 
considered as the main active ingredients and quality 
control reference in RDC. Therefore, the quality control 
of RDCFM was evaluated by the quantitative 
determination of citric acid and Dryocrassine ABBA 
using HPLC and visible spectrophotometry (Gao and Su, 
2009; Li et al., 2010). 
 
Virus:  A classical IBDV strain CJ801 was donated by 
Prof. Liu Jue, Beijing Institute of Husbandry and 
Veterinary Research. The LD50 of IBDV CJ801 strain for 
SPF chickens was determined to be 10
2.5 EID50 in 0.2 ml 
(Zhou et al., 2010).  
 
Chickens and experimental design: All the studies were 
performed on 4-week-old specific-pathogen-free (SPF) 
chickens (Vital Bridge Co. Ltd., Beijing, China). The 
experimental procedures and animal management were 
approved by the Institutional Animal Care and Use 
Committee at China Agricultural University. Seventy-two 
chickens were randomly divided into 6 groups and 
challenged intranasally with 0.2 ml IBDV CJ801 strain 
solution except the healthy control group. 24h post 
challenge, the birds were orally administered with 400 
mg/kg (high dosage group), 200 mg/kg (medium dosage 
group), 100 mg/kg body weight RDCFM (low dosage 
group), 125 mg/kg body weight ASP (positive control 
group), the same volume of solvent (infectious control 
group) and the no-treatment group (healthy control group). 
Each group was maintained in individual negative 
pressure isolators. All chickens were provided feed and 
water ad libitum. The body gain and mortality among all 
groups were monitored for 10 days. On day 10, the birds 
were euthanized and sacrificed to collect the serum 
samples for the detection of antibody and immune organs 
for determining the virus loads as well as the immune 
organs index. 
 
Quantification of IBDV in the bursa of Fabricius: The 
total RNA was isolated from the homogenated bursa of 
Fabricius using the RNeasy Mini Kit (Qiagen, Germany) 
according to the manufacturer’s protocol. Total RNA was 
then reverse transcribed into cDNA and amplified and 
quantified using the QuantiTect SYBR Green Kit 
(Qiagen, Germany). β-actin was used as a loading control. 
The primers were designed to amplify the VP2 gene and 
β-actin as previously described: IBDV-P1: 5’-AGA AGC 
ACA CTC TCA GGT CA-3’, IBDV-P2: 5’-AGT GTG 
CTT GAC CTC ACT GT-3’; β-actin-P1: 5’-CAT CAC 
CAT TGG CAA TGA GAGG-3’,  β-actin-P2: 5’-GCA 
AGC AGG AGT ACG ATG AATC-3’ (Tham et al., 1995; 
Khatri and Sharma, 2006). Each reaction was performed 
in triplicate using the above primers. The real-time PCR 
procedure was briefly described as follows: an initial 
incubation for 5 min at 94°C, 40 cycles of 30s at 94°C, 
30s at 68°C and 30s at 60°C. The quantification was 
based on the fluorescence detection by real-time PCR 
(Bio-Rad, USA). The viral amount in the samples was 
evaluated by relative quantification. 
 
Antibody detection: The antibody levels against IBDV 
were measured using a commercial test kit (BioChek, 
Holland). All procedures were performed according to the 
manufacturer’s instructions. Briefly, 100µl of diluted 
samples were added into the appropriate wells of IBDV-
coated plates. The positive serums and negative samples 
were also added to the wells. After several washes, the 
conjugate reagent and substrate reagent were added to 
react with above samples. Finally, 100µl of stop solution 
was added to terminate the reactions and the OD values 
were recorded at 405 nm.  
 
Statistical analysis: All data were expressed as the mean 
± standard error. The two-tailed one-way ANOVA was 
employed for all statistical analyses using SPSS 13.0. The 
results were considered significantly different at the level 
of P<0.05 or P<0.01. 
 
RESULTS 
 
Determination of citric acid and ABBA in RDCFM 
extract:  The chromatograms were shown in Fig. 1, 
including methanol control, positive citric acid control, 
RDCFM sample and standard curve. The retention time 
for citric acid was approximately 7.17 min while the 
calibration curve arranged from 0.2 to 2.4 mg/ml. The 
citric acid concentration was determined to be 120 mg per 
gram extract based on the regression equation Y=(1E-06) 
X+0.0072 (R
2=0.9997). As for the concentration of 
Dryocrassine ABBA, the regression equation was 
A=0.0703C+0.0436 and OD value was 0.568. Finally, the 
concentration of Dryocrassine ABBA was 7.459 mg per 
one gram of the RDCFM extract.  Pak Vet J, 2013, 33(3): 304-308. 
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Fig. 1: The content of citric acid was used to evaluate the quality of RDCFM. HPLC method was established with a VP-ODS C18 column and the 
mobile phase consisted of 0.02M potassium dihydrogen phosphate-methanol (93:7) at a flow rate of 1.0 ml/min. (a) Methanol was used as solvent 
control at the above condition, (b) the retention time for citric acid was approximately 7.049 min in the same condition, (c) the citric acid peak for 
sample solution appeared at 7.054 min, (d) the calibration curve arranged from 0.2 to 2.4 mg/ml and the regression equation was Y= (1E-06) 
X+0.0072 (R2=0.9997). 
 
Clinical performance and survival rate: After 
inoculated with IBDV, the chickens showed classical 
symptoms, such as decreased feed intake, fluffed feathers 
and diarrhea. Chickens died on day 3 post challenge and 
the mortality amounted to the peak on day 4. The 
remaining birds gradually recovered on day 7 and 
returned to normal activities on day 10.  
The survival rate, relative body gain rate and immune 
organs index were listed in Table 1. The survival rates 
were 66.7, 75.0 and 75.0% in the three RDCFM-treated 
groups, which were higher than those in the ASP and 
infection groups (58.0 and 50.0%). The relative weight 
gain rates in drug treatment groups (67.06, 67.92, 62.2 
and 64.96%) were significantly higher than that of the 
infection group (52.88%) (P<0.05).  
The RDCFM improved the spleen index in the three 
groups (3.06, 3.02 and 2.99) while only the bursa index in 
the 200 mg/kg group (up to 1.41) was higher than those in 
ASP and infection groups. 
 
Virus loads in bursa of Fabricius: The virus clearance 
was evaluated by the quantification of the IBDV genome 
in bursa organs. Based on a standard curve, the relative 
amount of viral RNA was calculated by log10CT in Fig. 2. 
The virus loads of the bursal organs in herbal groups were 
significantly lower than those of the ASP and infection 
groups (P<0.05). However, there were no significant 
differences among the three herbal groups.  
 
Antibody detection: The antibody levels for RDCFM 
groups, ASP group and infection group were shown in 
Fig. 3. Anti-IBDV antibody levels of the medium- and 
low-dosage groups were significantly higher (P<0.01) 
than those of the ASP and infection groups. Additionally, 
antibody level for the high-dosage group was also 
significantly higher than that of the ASP group (P<0.05).  
 
 
Fig. 2: Quantification of IBDV loads in the bursa of Fabricius in the 
experimental groups (400, 200 and 100 mg/kg BW, ASP and the 
infection group) using real-time RT-PCR. The data were expressed as 
the average ratio of IBDV/β-actin. * Indicates P<0.05 when the three 
herbal medicine-treated groups were compared to the ASP or infection 
group. 
 
 
 
Fig. 3: Serum samples were collected from chickens in all groups (400, 
200 and 100 mg/kg BW, ASP, infection and healthy group) at days10 
post challenge and antibody levels against IBDV were measured by 
ELISA kit. **
  Indicates P<0.01 when the medium- and low-dosage 
groups were compared to the ASP or infection group at days 10 post 
challenge. *
 Indicates P<0.05 when the high dosage group was compared 
to the ASP or infection group at days 10 post challenge. ## Indicates 
P<0.01 when the healthy group was compared to the ASP or infection 
group at days 10 post challenge day. 
 
DISCUSSION 
 
In the present study, the survival rate amounted to 
75% both in the medium and low concentration of 
RDCFM. Meanwhile, body weight gains, antibody level, 
virus clearances and immune organ index in the three Pak Vet J, 2013, 33(3): 304-308. 
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Table 1: The effects of herbal extracts on chickens’ performance post challenge with IBDV 
Groups  No.  Initial BW  Final BW  BWG  SN  SR (%)  BI  SI 
400mg/kg 12  210.4±24.2  333.8±10.1
* 123.3  8  66.7 1.20±0.301  3.06±0.624 
200mg/kg 12  210.1±23.1  335.1±6.3
* 125.0  9  75.0  1.41±0.478  3.02±0.824 
100mg/kg 12  211.5±21.7  325.9±9.7
* 124.4  9  75.0  1.19±0.422  2.99±0.841 
ASP 12  210.7±25.0  330.1±10.1
* 119.5  7  58.3 1.23±0.591  2.86±0.409 
Infection control  12  211.1±23.3  309.0±8.7  98.9  6  50.0  1.24±0.490  2.53±0.481 
Healthy control   12  210.3±23.3  394.2±31.6
** 183.9  12 100  1.73±0.811  3.07±0.967 
* P<0.05, 
**P<0.01; BW: body weight; BWG: body weight gain; SN: survival number; SR: survival rate; ASP: Astragalus polysaccharide BWG = Final 
BW-Initial BW; SR = SN/No ×100%; BI= weight of bursa (mg)/Final BW×1000; SI= weight of spleen (mg)/Final BW×1000 
 
RDCFM -treated groups were found to be improved post 
challenge with IBDV as compared to those of the 
infectious and ASP groups. The quality control of 
RDCFM was also evaluated by determining the content of 
citric acid and dryocrassine ABBA. Thus, the RDCFM 
could be produced in large number under the strict quality 
control. Based on the above evidence, RDCFM might be a 
promising substance against IBDV in the poultry industry 
as an alternative medicate to ASP and egg yolk antibody. 
The hemorrhagic lesions in immune organs have been 
recorded post infection with several IBDV isolates and 
mortality ranged from 30 to 100% in chickens (Aricibasi 
et al., 2010). In this experiment, the protection rate was an 
objective index to evaluate the efficacy of the combined 
extracts. A significant survival rate was observed both in 
the medium group and in the lower herbal-treated group 
as compared to ASP group, which implied that RDCFM 
had the therapeutic efficacy against IBDV infection. In the 
previous reports, spleen and bursa are the target organs of 
IBDV (Zierenberg et al., 2004). Therefore, the immune 
organs indexes are used for determining the lesions in 
spleen and bursa post IBDV infection. Obviously, 200 
mg/kg herbal extract was found to have a significant 
increase of spleen index as well as a good protection of 
bursa in comparison with ASP and infection groups. 
The high levels of antibody responses would induce 
the significant protection against the virulent IBDV 
infection (Hsieh et al., 2010). In our experiment, higher 
antibody levels in the three herbal extract groups were 
corresponded with the higher body weight gain, the 
increasing survival rate, lower virus load and better 
immune organ indexes post IBDV infection. In this sense, 
the infected chickens could get protection due to 
improving birds’ appetite and humoral immunity. In 
previous reports, chickens administered with ASP were 
able to get a good protection against IBDV infection due 
to the increasing erythrocyte-C3b receptor and the 
immune complex rosette rate (Li et al., 2007). Hence, the 
combined herbal extracts might involve the protection of 
B cells in the bursa of Fabricius and induce higher 
antibody levels post IBDV infection.  
Until recently, both the egg yolk antibody and ASP 
have been accredited for legal veterinary drugs against 
IBDV in China. Particularly, these substances are 
complementary approach for vaccine failure, early 
subclinical infections and the occurrence of the virulent 
IBDV strains in the field (Kibenge et al., 1988). 
Nevertheless, the application of egg yolk antibody caused 
multiple adverse effects, such as the risk of secondary 
infection and immune depression (Hatta et al., 2008). 
Furthermore, the egg yolk antibody is not suitable for 
clinical applications in large poultry flocks due to the 
intensive labor requirement. Currently, Chinese farmers 
turn to large amounts of ASP in routine treatments for 
antiviral activity. As a result, forthcoming viral resistance 
will be inevitable in the poultry industry. The potential 
outbreak of new very virulent strains will challenge the 
health of poultry. Therefore, RDCFM might be an 
alternative to ASP and egg yolk antibody as a new 
medicatement against IBDV infection.  
Based on the evidence presented here, we conclude 
that RDCFM is a promising medication against IBDV 
infection by improving antibody level and decreasing 
virus load in the targeted organs. Further investigations 
will be performed to understand the mechanism of the 
herbal extract and expand the potential application of 
RDCFM against other avian viral diseases. 
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